The Pathogenesis Characteristics and Symptom of Covid-19 in the Context of Establishing a Nursing Diagnosis

Mayusef Sukmana, Falasifah Ani Yuniarti


Covid-19 is a disease that causes a global health emergency, caused by SAR-CoV2 and transmitted through droplets. Viruses attached to host cells are strongly bound to ACE2 causing excessive inflammatory reactions (Cytokine Storm). The incubation period 1-14 days, causing signs and symptoms of the respiratory syndrome, fever, leukopenia, thrombocytopenia, and in severe conditions multi-organ failure that ends in death. In May 2020 the world mortality rate increased by 15.45%, which previously was March 2020 at 3.4%. The concept of pathogenesis is needed as an effort to provide understanding in handling Covid-19 so that mortality can be controlled. Tracing and understanding the characteristics of Covid-19 pathogenesis that gives rise to various pathological responses of the body becomes an interesting analytical study to establish an appropriate diagnosis, including nursing diagnoses in order to develop a comprehensive nursing plan. This study aims to review the characteristics of covid-19 pathogenesis in the context of establishing a nursing diagnosis according to the Indonesian Nursing Diagnosis Standards.  A literature study is done by analyzing the characteristics of COVID-19 signs and symptoms and comparing the major and minor data groupings that exist in the Indonesian Nursing Diagnosis Standard. Characteristic pathogenesis results from mild, moderate and severe symptoms. Grouping results refer to nursing diagnoses including ineffective airway clearance, ventilator weaning disorders, gas exchange disorders, ineffective breathing patterns, the risk of spontaneous circulatory disorders, hyperthermia and anxiety.

 Keywords: Nursing diagnosis Covid-19, signs anda symptome covid-19,  pathogenesis Covid-19, SAR-CoV2


Full Text:



(JHU), J. H. U. (2020). Center for Systems Science and Engineering (CSSE).

Ackermann, M., Verleden, S. E., Kuehnel, M., Haverich, A., Welte, T., Laenger, F., … Jonigk, D. (2020). Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19. New England Journal of Medicine, 1–9.

Albarello, F., Pianura, E., Di Stefano, F., Cristofaro, M., Petrone, A., Marchioni, L., … Ippolito, G. (2020). 2019-novel Coronavirus severe adult respiratory distress syndrome in two cases in Italy: An uncommon radiological presentation. International Journal of Infectious Diseases, 93( PG -), 192–197.

Bastola, A., Sah, R., Rodriguez-Morales, A. J., Lal, B. K., Jha, R., Ojha, H. C., … Pandey, B. D. (2020). The first 2019 novel coronavirus case in Nepal. The Lancet Infectious Diseases, 20(3), 279–280.

Bhatraju, P. K., Ghassemieh, B. J., Nichols, M., Kim, R., Jerome, K. R., Nalla, A. K., … Mikacenic, C. (2020). Covid-19 in Critically Ill Patients in the Seattle Region — Case Series. New England Journal of Medicine, 2012–2022.

BNPB. (2020). Data sebaran covid-19 di Indonesia. Retrieved from

Bowles, L., Platton, S., Yartey, N., Dave, M., Lee, K., Hart, D. P., … MacCallum, P. (2020). Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19. The New England Journal of Medicine, 1–2.

Brooks, S. K., Webster, R. K., Smith, L. E., Woodland, L., Wessely, S., Greenberg, N., & Rubin, G. J. (2020). The psychological impact of quarantine and how to reduce it: rapid review of the evidence. The Lancet, 395(10227), 912–920.

Cuong, L. Van, Thi, H., Giang, N., Linh, L. K., Shah, J., Sy, L. Van, … Huy, N. T. (2020). Correspondence The first Vietnamese case of COVID-19. The Lancet Infectious Diseases, 3099(20), 19–20.

Fardin, M. A. (2020). COVID-19 and Anxiety: A Review of Psychological Impacts of Infectious Disease Outbreaks. Archives of Clinical Infectious Diseases, 15(COVID-19), 11–13.

Fourrier, F. (2003). Disseminated intravascular coagulation. Sang Thrombose Vaisseaux, 15(6), 333–339.

Frater, J. L., Zini, G., D’Onofrio, G., & Rogers, H. J. (2020). COVID-19 and the clinical hematology laboratory. International Journal of Laboratory Hematology, (2), 0–3.

Fu, Y., Cheng, Y., & Wu, Y. (2020). Understanding SARS-CoV-2-Mediated Inflammatory Responses: From Mechanisms to Potential Therapeutic Tools. Virologica Sinica, 12250.

Gandhi, R. T., Lynch, J. B., & del Rio, C. (2020). Mild or Moderate Covid-19. New England Journal of Medicine, 1–9.

Geng, Y.-J., Wei, Z.-Y., Qian, H.-Y., Huang, J., Lodato, R., & Castriotta, R. J. (2020). Pathophysiological Characteristics and Therapeutic Approaches for Pulmonary Injury and Cardiovascular Complications of Coronavirus Disease 2019. Cardiovascular Pathology, 47, 107228.

Go, Y. Y., Kim, Y., Cheon, S., Nam, S., Ku, B., Kim, M., & Cho, H. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet (London, England), 395(January), 497–506.

Guan, W., Ni, Z., Hu, Y., Liang, W., Ou, C., He, J., … Zhu, S. (2020). Clinical Characteristics of Coronavirus Disease 2019 in China. New England Journal of Medicine, 1–13.

Helms, J., Kremer, S., Merdji, H., Clere-Jehl, R., Schenck, M., Kummerlen, C., … Meziani, F. (2020). Neurologic Features in Severe SARS-CoV-2 Infection. New England Journal of Medicine, 1–2.

Karisma, A. (2020). Anestesi Pada Pasien Hipertensi.

Kim, J. Y., Choe, P. G., Oh, Y., Oh, K. J., Kim, J., Park, S. J., … Oh, M. D. (2020). The first case of 2019 novel coronavirus pneumonia imported into korea from wuhan, china: Implication for infection prevention and control measures. Journal of Korean Medical Science, 35(5), 1–4.

Li, X., Geng, M., Peng, Y., Meng, L., & Lu, S. (2020). Molecular immune pathogenesis and diagnosis of COVID-19. Journal of Pharmaceutical Analysis, 10(2), 102–108.

Liu, J., Zheng, X., Tong, Q., Li, W., Wang, B., Sutter, K., … Yang, D. (2020). Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS‐CoV, MERS‐CoV, and 2019‐nCoV. Journal of Medical Virology, (February), 1–4.

Martinez, F. J. (2020). Severe Covid-19. The New England Journal of Medicine, 1–10.

McGonagle, D., O’Donnell, J., Sharif, K., Emery, P., & Bridgewood, C. (2020). Immune Mechanisms of Pulmonary Intravascular Coagulopathy (PIC) in COVID-19 Pneumonia. The Lancet Rheumatology, 2019(20), 1–9.

McGonagle, D., Sharif, K., O’Regan, A., & Bridgewood, C. (2020). The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease. Autoimmunity Reviews, (March), 102537.

Mcmurray, J. J. V, Pfeffer, M. A., Ph, D., & Solomon, S. D. (2020). Special Report Renin – Angiotensin – Aldosterone System Inhibitors in Patients with Covid-19. 1653–1659.

Mehta, P., McAuley, D. F., Brown, M., Sanchez, E., Tattersall, R. S., & Manson, J. J. (2020). COVID-19: consider cytokine storm syndromes and immunosuppression. The Lancet, 395(10229), 1033–1034.

MHPSS Reference Group. (2020). Catatan Tentang Aspek Kesehatan Jiwa dan Psikososial Wabah Covid-19 Versi 1.0. IASC, pp. 1–20.

Patients, L., Taylor, D., Lindsay, A. C., & Halcox, J. P. (2020). Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. The New England Journal of Medicine, 0–3.

Pedersen, S. F. & Y. C. H. (2020). CoV-2: a storm is raging. Journal Clinical Investigation, 2202–2203.

PPNI. (2016). Standar Diagnosis Keperawatan Indonesia, Definisi dan Indikator Diagnostik, Edisi 1 Cetakan III(revisi). Jakarta: DPP PPNI.

Puyo, C. A., & Dahms, T. E. (2012). Innate immunity mediating inflammation secondary to endotracheal intubation. Archives of Otolaryngology - Head and Neck Surgery, 138(9), 854–858.

Sahin, A. R. (2020). 2019 Novel Coronavirus (COVID-19) Outbreak: A Review of the Current Literature. Eurasian Journal of Medical Investigation, 4(1), 1–7.

Sise, M. E., Baggett, M. V, Shepard, J.-A. O., Stevens, J. S., & Rhee, E. P. (2020). Case 17-2020: A 68-Year-Old Man with Covid-19 and Acute Kidney Injury. The New England Journal of Medicine, 1–10.

Song, F., Shi, N., Shan, F., Zhang, Z., Shen, J., Lu, H., … Shi, Y. (2020). Emerging 2019 novel coronavirus (2019-NCoV) pneumonia. Radiology, 295(1), 210–217.

Sukmana, M., Aminuddin, M., & Nopriyanto, D. (2020). Indonesian Government Response In COVID-19 Disaster Prevention. East African Scholars Journal of Medical Sciences, 3(3), 81–86.

Sun, P., Lu, X., Xu, C., Sun, W., & Pan, B. (2020). Understanding of COVID-19 based on current evidence. Journal of Medical Virology, (February), 10–13.

Tang, N., Li, D., Wang, X., & Sun, Z. (2020). Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. Journal of Thrombosis and Haemostasis, 18(4), 844–847.

Tim Kerja Kementerian Dalam Negeri. (2020). Pedoman Umum Menghadapi Pandemi Covid-19 Bagi Pemerintah Daerah : Pencegahan, Pengendalian, Diagnosis dan Manajemen. Journal of Chemical Information and Modeling.

Ulhaq ZS; GV, S. (2020). Interleukin-6 as a potential biomarker of Covi-19 progression. Med Mal Infect, (January), 19–20.

Wahyuniati, N., & Maulana, R. (2015). Peran Interleukin-10 Pada Infeksi Malaria. Jurnal Kedokteran Syiah Kuala, 15(2), 96–103.

Walter, E. J., Hanna-Jumma, S., Carraretto, M., & Forni, L. (2016). The pathophysiological basis and consequences of fever. Critical Care, 20(1), 1–10.

Wei, W. E., Li, Z., Chiew, C. J., Yong, S. E., Toh, M. P., & Lee, V. J. (2020). Presymptomatic Transmission of SARS-CoV-2-Singapore. Morbidity and Mortality Weekly Report, 69(14), 411–415.

WHO. (2020). Q&A on coronaviruses (COVID-19).

World Health Organization (WHO)-China Joint Mission on Coronavirus Disease 2019. (2020). Report of the WHO-China Joint Mission on Coronavirus Disease 2019 ( COVID-19 ).

Wu, J., Liu, J., Zhao, X., Liu, C., Wang, W., Wang, D., … Li, L. (2020). Clinical Characteristics of Imported Cases of COVID-19 in Jiangsu Province: A Multicenter Descriptive Study. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America.

Yang, W., Cao, Q., Qin, L., Wang, X., Cheng, Z., Pan, A., … Yan, F. (2020). Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19):A multi-center study in Wenzhou city, Zhejiang, China. Journal of Infection, 80(4), 388–393.



  • There are currently no refbacks.

Indexing by :